Caspase inhibitors as neuroprotective agents

By Legos J.J.   Lee D.   Erhardt J.A.  

Expert Opinion on Emerging Drugs, Vol. 6, Iss. 1, 2001-04 ,pp. : 81-94

Informa Healthcare

Access to resources Recommend Favorite

Novel approaches for the design and discovery of quorum-sensing inhibitors

By Scutera Sara   Zucca Mario   Savoia Dianella  

Expert Opinion on Drug Discovery, Vol. 9, Iss. 4, 2014-04 ,pp. : 353-366

Informa Healthcare

Access to resources Recommend Favorite

Proteasome inhibitors: possible novel therapeutic strategy for ischemia–reperfusion injury?

By Kandilis Apostolos N   Karidis Nikolaos P   Kouraklis Gregory   Patsouris Efstratios   Vasileiou Ioanna   Theocharis Stamatios  

Expert Opinion on Investigational Drugs, Vol. 23, Iss. 1, 2014-01 ,pp. : 67-80

Informa Healthcare

Access to resources Recommend Favorite

Towards new neuroprotective agents: design and synthesis of 4H-thieno[2,3-c] isoquinolin-5-one derivatives as potent PARP-1 inhibitors

By Pellicciari R.   Camaioni E.   Costantino G.   Marinozzi M.   Macchiarulo A.   Moroni F.   Natalini B.  

Il Farmaco, Vol. 58, Iss. 9, 2003-09 ,pp. : 851-858

Elsevier

Access to resources Recommend Favorite

Investigations of new lead structures for the design of novel cyclooxygenase-2 inhibitors

By Park C.H.   Siomboing X.   Yous S.   Gressier B.   Luyckx M.   Chavatte P.  

European Journal of Medicinal Chemistry, Vol. 37, Iss. 6, 2002-06 ,pp. : 461-468

Elsevier

Access to resources Recommend Favorite